HAp-IFN

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameHAp-IFN
Drug Alias NameHydroxyapatite-IFN (LTT Bio-Pharma)
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionInterferon alpha 2 ligand
TargetsInterferon alpha-2
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLTT Bio-Pharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLTT Bio-Pharma Co Ltd
Active IndicationsN/A
Inactive IndicationsHepatitis C

Other Information

ATC CodeN/A
Related LinksN/A